What is OrthoPediatrics's G&A?

OrthoPediatrics (KIDS) reported G&A of $31.02M in Q1 2026.

How has OrthoPediatrics's G&A changed year-over-year?

OrthoPediatrics's G&A increased by 2.5% year-over-year, from $30.28M to $31.02M.

What is the long-term trend for OrthoPediatrics's G&A?

Over 4 years (2021 to 2025), OrthoPediatrics's G&A has grown at a 27.0% compound annual growth rate (CAGR), from $46.06M to $119.83M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

OrthoPediatrics KIDS G&A

G&A at other companies

SI-BONE, Inc.SIBN

$10.04M+0.8%

CONMEDCNMD

$32.4M-0.8%

Carlsmed, Inc. Common StockCARL

$6.23M+79.6%

Other financials

Income statement

See full

Revenue$59.4M+13.3%

Gross profit$43.4M+13.4%

Operating income-$8.3M+24.1%

Net income-$10.7M-0.3%

EPS (diluted)-$0.45+2.2%

Balance sheet

See full

Cash & equivalents$14.2M-59.8%

Total debt$5.4M+271%

Total equity$338.7M-2.4%

Total assets$502.2M+6.8%

Cash flow

See full

Operating cash flow-$3.3M+20.9%

CapEx$1.8M-58.4%

Free cash flow-$5.0M+39.8%

Valuation

See full

Market cap$503.94M+0.3%

Enterprise value$495.11M+5.7%

P/S2.1×-0.3×

Profitability

See full

Gross margin73.1%+0.3pp

Operating margin-15%-1.6pp

Net margin-16.3%-2.1pp

FCF margin-12.9%-4.3pp

Returns & leverage

See full

Return on equity-11.6%+0.2pp

Debt / equity0×0.0×

Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OrthoPediatrics's G&A?: OrthoPediatrics (KIDS) reported G&A of $31.02M in Q1 2026.
How has OrthoPediatrics's G&A changed year-over-year?: OrthoPediatrics's G&A increased by 2.5% year-over-year, from $30.28M to $31.02M.
What is the long-term trend for OrthoPediatrics's G&A?: Over 4 years (2021 to 2025), OrthoPediatrics's G&A has grown at a 27.0% compound annual growth rate (CAGR), from $46.06M to $119.83M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.